February 28, 2025

Efficacy and safety of rituximab in anti-MuSK myasthenia Gravis: a systematic review and meta-analysis – Nature

February 25, 2025

The economic burden of Myasthenia gravis from the patient´s perspective and reflected in German claims data – Nature

February 18, 2025

After 10 Years of Hard Work, COUR Treads Into Pharma’s Myasthenia Gravis Territory – BioSpace

February 18, 2025

Risk Factors for Myasthenic Crisis in Patients With Myasthenia Gravis: A Retrospective Study in Southwest China – Wiley Online Library

January 30, 2025

Successful treatment of generalized myasthenia gravis with telitacicept: a Chinese case series and literature review – Frontiers